Aurinia Pharmaceuticals, Inc. (AUPH)
15.98
-0.16
(-0.99%)
USD |
NASDAQ |
Apr 24, 16:00
16.00
+0.02
(+0.09%)
Pre-Market: 20:00
Aurinia Pharmaceuticals Market Cap : 2.125B for April 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Xenon Pharmaceuticals, Inc. | 5.271B |
| Oncolytics Biotech, Inc. | 119.61M |
| Edesa Biotech, Inc. | 60.50M |
| Lexaria Bioscience Corp. | 23.39M |
| ProMIS Neurosciences, Inc. | 24.19M |
Market Cap Related Metrics
| PE Ratio | 7.693 |
| PS Ratio | 7.832 |
| PEG Ratio | 0.0015 |
| Price to Book Value | 3.655 |
| Price to Free Cash Flow | 16.34 |
| Price | 15.98 |
| Earnings Yield | 13.00% |
| PEGY Ratio | 0.0015 |
| Operating PE Ratio | 19.10 |
| Normalized PE Ratio | 7.664 |